ReviewJournal of hematology & oncology2013
Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing.
Ruben A Mesa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled ittrialcites it